Skip to main content

Press releases

2018-04-19
STOCKHOLM, April 19th, 2018, Moberg Pharma AB (OMX: MOB) announces that Kjell Rensfeldt, VP Research and Development, will retire in the fall but remain with the company part-time as Senior Adviser.
2018-04-10
Shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the “Company”) are hereby convened to the Annual General Meeting on Tuesday, May 15, 2018 at 5:00 p.m. (CET) in the Company’s premises in Bromma, address Gustavslundsvägen 42, 5 tr, 167 51 Bromma (Alviks torg), Sweden.
2018-04-10
Moberg Pharma´s Annual Report for 2017 has been published and is available on www.mobergpharma.com
2018-03-13
STOCKHOLM, March 13th, 2018. Moberg Pharma AB (OMX: MOB) announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2018.
2018-02-28
STOCKHOLM, February 28th 2018, Moberg Pharma AB (OMX: MOB) has entered into an agreement with Randob Labs to divest the brand Balmex® for a total consideration of $4.25 million (34.6 million SEK) plus the inventory value at closing. The divestment is expected to result in a capital gain of circa $0.5 million (4.4 million SEK), enabling Moberg Pharma to further focus resources on its larger brands.
2018-02-13
STRONG GROWTH FOR KERASAL NAIL INCREASES EBITDA
2018-02-06
STOCKHOLM, February 6th, 2018 - On February 13th 2018, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Year-end report 2017. Investors, analysts and journalists are hereby invited to participate in a teleconference at 03:00 pm (CET) on the same date.
2018-01-15
STOCKHOLM, January 15th, 2018 - Moberg Pharma AB (OMX: MOB) have received a positive outcome from the NAD (National Advertising Division) regarding a challenge filed on Fungi-Nail, the largest U.S. competitor to the Kerasal Nail® product. NAD recommends the advertiser to discontinue current product packaging and commercials. Moberg Pharma expects the outcome to further strengthen Kerasal Nails® position and growth prospects in the U.S. market.